Back to All Events
In this talk at the 6th annual Advances in Circulating Tumor Cells meeting, BLOODPAC's Executive Director Lauren C. Leiman will discuss the organization's major achievements from the past several years, including:
The publication of our Minimal Technical Elements for liquid biopsy data collection and submission to repositories
BLOODPAC’s Generic Protocols for analytical validation of ctDNA-based assays
Our progress in defining the pathways to implementation of liquid biopsy for cancer early detection and screening
Our Global Regulatory group's progress in facilitating international regulatory standards for diagnostic testing with liquid biopsy